TGR5 represents a compelling molecular target for addressing the multifactorial pathogenesis of obesity, encompassing energy imbalance, insulin resistance, and dysregulated gut hormone signaling. Here, GPBAR1 is linked to obesity due to melanocortin 4 receptor deficiency.